Renalytix Plc Share Price BOERSE MUENCHEN
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.193 EUR | 0.00% |
|
+13.53% | -1.03% |
06-14 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
06-14 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
Sales 2024 * | 2.5M 2.33M 197M | Sales 2025 * | 9.6M 8.93M 755M | Capitalization | 34.28M 31.89M 2.7B |
---|---|---|---|---|---|
Net income 2024 * | -33M -30.7M -2.6B | Net income 2025 * | -26M -24.19M -2.05B | EV / Sales 2024 * | 13.7 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 week | +13.53% | ||
Current month | +22.15% | ||
1 month | -36.51% | ||
3 months | -52.93% | ||
6 months | -7.21% | ||
Current year | -1.03% |
![Extreme 0.17](/images/extremecours_fleche.png)
![Extreme 0.151](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 14/03/18 |
Howard Doran
PSD | President | 63 | 31/08/23 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/03/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 29/08/21 |
Chairman | 72 | 14/03/18 | |
James McCullough
FOU | Founder | 56 | 14/03/18 |
Date | Price | Change |
---|---|---|
18/06/24 | 0.193 | 0.00% |
17/06/24 | 0.193 | -18.91% |
14/06/24 | 0.238 | +40.00% |
13/06/24 | 0.17 | 0.00% |
12/06/24 | 0.17 | 0.00% |
Real-time BOERSE MUENCHEN, June 18, 2024 at 02:43 pm
More quotes![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.98% | 16.07B | |
-50.30% | 2.43B | |
+27.80% | 2.02B | |
-7.88% | 1.53B | |
+27.15% | 1.29B | |
-19.07% | 931M | |
-32.38% | 772M | |
-0.66% | 761M | |
-25.61% | 619M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock